Acrivon Therapeutics Inc (ACRV)
8.88
+0.32
(+3.74%)
USD |
NASDAQ |
May 17, 16:00
8.88
0.00 (0.00%)
After-Hours: 20:00
Acrivon Therapeutics Price to Book Value: 2.542 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.542 |
| May 16, 2024 | 2.448 |
| May 15, 2024 | 2.474 |
| May 14, 2024 | 2.391 |
| May 13, 2024 | 2.425 |
| May 10, 2024 | 2.508 |
| May 09, 2024 | 2.328 |
| May 08, 2024 | 2.353 |
| May 07, 2024 | 2.385 |
| May 06, 2024 | 2.525 |
| May 03, 2024 | 2.742 |
| May 02, 2024 | 2.419 |
| May 01, 2024 | 2.353 |
| April 30, 2024 | 2.599 |
| April 29, 2024 | 2.859 |
| April 26, 2024 | 2.419 |
| April 25, 2024 | 2.422 |
| April 24, 2024 | 2.716 |
| April 23, 2024 | 2.808 |
| April 22, 2024 | 2.719 |
| April 19, 2024 | 2.685 |
| April 18, 2024 | 3.014 |
| April 17, 2024 | 2.956 |
| April 16, 2024 | 2.708 |
| April 15, 2024 | 2.748 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.856 |
| April 11, 2024 | 2.656 |
| April 10, 2024 | 2.178 |
| April 09, 2024 | 2.017 |
| April 08, 2024 | 1.239 |
| April 05, 2024 | 1.358 |
| April 04, 2024 | 1.402 |
| April 03, 2024 | 1.396 |
| April 02, 2024 | 1.402 |
| April 01, 2024 | 1.520 |
| March 28, 2024 | 1.336 |
| March 27, 2024 | 1.208 |
| March 26, 2024 | 1.182 |
| March 25, 2024 | 1.167 |
| March 22, 2024 | 1.150 |
| March 21, 2024 | 1.176 |
| March 20, 2024 | 1.169 |
| March 19, 2024 | 1.016 |
| March 18, 2024 | 1.05 |
| March 15, 2024 | 1.150 |
| March 14, 2024 | 0.9422 |
| March 13, 2024 | 0.9812 |
| March 12, 2024 | 0.9273 |
| March 11, 2024 | 0.9199 |
| March 08, 2024 | 0.9199 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5832
Minimum
Nov 21 2023
3.014
Maximum
Apr 18 2024
1.540
Average
1.629
Median
Price to Book Value Benchmarks
| MyMD Pharmaceuticals Inc | 0.4148 |
| Vincerx Pharma Inc | -- |
| GlycoMimetics Inc | 0.6676 |
| Immunic Inc | 1.342 |
| Skye Bioscience Inc | 4.288 |
Price to Book Value Related Metrics
| Price | 8.88 |
| Earnings Yield | -32.51% |
| Market Cap | 274.50M |